Beam Therapeutics Inc header image

Beam Therapeutics Inc

BEAM

Equity

ISIN null / Valor 50337226

NASDAQ (2025-12-24)
USD 28.14+1.33%

Beam Therapeutics Inc
UMushroom community rating:

star star star star star
4.00 4 votes No rating yet
NegativeNeutralPositive

About company

Beam Therapeutics Inc is a biotechnology company focused on developing innovative gene editing technologies to treat a wide range of genetic diseases. The company's delivery strategy involves utilizing a suite of clinically validated technologies, including electroporation, nonviral, and viral delivery modalities, to efficiently and precisely edit genes. Beam Therapeutics Inc aims to revolutionize the field of gene editing by providing novel solutions for patients with genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-2.33%1Y
-30.3%3Y
-68.0%5Y

Performance

76.2%1Y
69.7%3Y
77.5%5Y

Volatility

Market cap

2856 M

Market cap (USD)

Daily traded volume (Shares)

430,288

Daily traded volume (Shares)

1 day high/low

26.41 / 24.77

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

4 votes
Performance:
starstarstarstarstar
3.75
Innovation:
starstarstarstarstar
3.25
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.75
Fabio Kull
Switzerland, 30 Oct 2025
star star star star star
promising biotech company focused on precise gene editing. The stock is innovative but risky
Carlos Mayes
United Kingdom, 21 Oct 2025
star star star star star
Strong growth currently
Ben Marshall
United Kingdom, 21 Oct 2025
star star star star star
Currently performing very well however has potential to fall off completely soon

EQUITIES OF THE SAME SECTOR

Navitas Semiconductor Corporation
Navitas Semiconductor Corporation Navitas Semiconductor Corporation Valor: 114384839
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 7.66
Mercury Systems Inc
Mercury Systems Inc Mercury Systems Inc Valor: 847694
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%USD 74.70
BlackBerry Ltd
BlackBerry Ltd BlackBerry Ltd Valor: 21892856
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%CAD 5.46
Softchoice Corporation
Softchoice Corporation Softchoice Corporation Valor: 111601375
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%CAD 24.49
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc SpringWorks Therapeutics Inc Valor: 49628191
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 46.99
Rapid7 Inc
Rapid7 Inc Rapid7 Inc Valor: 28570046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.33%USD 15.33
Alstom SA
Alstom SA Alstom SA Valor: 2229080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%EUR 24.96
Nexans
Nexans Nexans Valor: 1242479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%EUR 124.80
OVH GROUPE
OVH GROUPE OVH GROUPE Valor: 114137816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.53%EUR 7.29
Assystem SA
Assystem SA Assystem SA Valor: 1007707
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%EUR 41.40